Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Alzheimers Disease Drug Market aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug. Alzheimers Disease Drug Market contains market size and forecasts of Alzheimer's Disease Drug in global, including the following market information:
- Global Alzheimer's Disease Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Alzheimer's Disease Drug Market Sales, 2018-2023, 2024-2029, (K Units)
- Global top five Alzheimer's Disease Drug companies in 2022 (%)
The global Alzheimer's Disease Drug market was valued at US$ 3722.7 million in 2022 and is projected to reach US$ 4113.3 million by 2029, at a CAGR of 1.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Alzheimer?s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
We surveyed the Alzheimer's Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer's Disease Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Alzheimer's Disease Drug Market Segment Percentages, by Type, 2022 (%)
- Donepezil
- Memantine
- Rivastigmine
- Others
Global Alzheimer's Disease Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Alzheimer's Disease Drug Market Segment Percentages, by Application, 2022 (%)
- Early to Moderate Stages
- Moderate to Severe Stages
Global Alzheimer's Disease Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Alzheimer's Disease Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Alzheimer's Disease Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Alzheimer's Disease Drug revenues share in global market, 2022 (%)
- Key companies Alzheimer's Disease Drug sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Alzheimer's Disease Drug sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Allergan
- Eisai
- Novartis
- Daiichi Sankyo
- Merz Pharma
- Pfizer
- Johnson & Johnson
- Lundbeck
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Alzheimer's Disease Drug, market overview.
- Chapter 2: Global Alzheimer's Disease Drug market size in revenue and volume.
- Chapter 3: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Alzheimer's Disease Drug capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
